measles/mumps/rubella/varicella vaccine (live-attenuated) (Beijing Tiantan Biological Products)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namemeasles/mumps/rubella/varicella vaccine (live-attenuated) (Beijing Tiantan Biological Products)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRubivirus InfectionsMumpsMorbillivirus Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Tiantan Biological Products Corporation Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Tiantan Biological Products Corporation Ltd
Active IndicationsN/A
Inactive IndicationsRubivirus InfectionsMumpsMorbillivirus Infections +[4] 

Other Information

ATC CodeN/A
Related LinksN/A